In lab experiments, bacteria transferred plasmids with AMR genes in the presence of zinc at reduced or nonexistent rates. Stopping the transfer without killing microbes may help reduce AMR without ...

Vaxcyte is positioned to disrupt the pneumococcal vaccine market with its engineered VAX-31, overcoming carrier suppression limitations faced by incumbents. PCVX's $2.7B cash position supports an ...

Radiopharmaceuticals are one of the most exciting frontiers in oncology and targeted therapies today. By combining biologically active molecules with radionuclides, radiopharmaceuticals can deliver ...